Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,395 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of an artificial intelligence based model to predict non-transplantable recurrence among patients with hepatocellular carcinoma.
Altaf A, Endo Y, Munir MM, Khan MMM, Rashid Z, Khalil M, Guglielmi A, Ratti F, Marques H, Cauchy F, Lam V, Poultsides G, Kitago M, Popescu I, Martel G, Gleisner A, Hugh T, Shen F, Endo I, Pawlik TM. Altaf A, et al. Among authors: endo y, endo i. HPB (Oxford). 2024 Aug;26(8):1040-1050. doi: 10.1016/j.hpb.2024.05.006. Epub 2024 May 16. HPB (Oxford). 2024. PMID: 38796346
Efficacy and safety of preoperative 5-fluorouracil, cisplatin, and mitomycin C in combination with radiotherapy in patients with resectable and borderline resectable pancreatic cancer: a long-term follow-up study.
Endo Y, Kitago M, Aiura K, Shinoda M, Yagi H, Abe Y, Oshima G, Hori S, Nakano Y, Itano O, Fukada J, Masugi Y, Kitagawa Y. Endo Y, et al. World J Surg Oncol. 2019 Aug 16;17(1):145. doi: 10.1186/s12957-019-1687-4. World J Surg Oncol. 2019. PMID: 31420046 Free PMC article.
Clinicopathological impacts of DNA methylation alterations on pancreatic ductal adenocarcinoma: prediction of early recurrence based on genome-wide DNA methylation profiling.
Endo Y, Fujimoto M, Ito N, Takahashi Y, Kitago M, Gotoh M, Hiraoka N, Yoshida T, Kitagawa Y, Kanai Y, Arai E. Endo Y, et al. J Cancer Res Clin Oncol. 2021 May;147(5):1341-1354. doi: 10.1007/s00432-021-03541-6. Epub 2021 Feb 26. J Cancer Res Clin Oncol. 2021. PMID: 33635431 Free PMC article.
Application of Hazard Function to Investigate Recurrence of Intrahepatic Cholangiocarcinoma After Curative-Intent Liver Resection: A Novel Approach to Characterize Recurrence.
Alaimo L, Moazzam Z, Brown ZJ, Endo Y, Ruzzenente A, Guglielmi A, Aldrighetti L, Weiss M, Bauer TW, Alexandrescu S, Poultsides GA, Maithel SK, Marques HP, Martel G, Pulitano C, Shen F, Soubrane O, Koerkamp BG, Endo I, Pawlik TM. Alaimo L, et al. Among authors: endo y, endo i. Ann Surg Oncol. 2023 Mar;30(3):1340-1349. doi: 10.1245/s10434-022-12463-7. Epub 2022 Aug 27. Ann Surg Oncol. 2023. PMID: 36029379
Impact of tumor burden score on timing and patterns of recurrence after curative-intent resection of hepatocellular carcinoma.
Moazzam Z, Lima HA, Alaimo L, Endo Y, Shaikh CF, Ratti F, Marques HP, Soubrane O, Lam V, Poultsides GA, Popescu I, Alexandrescu S, Martel G, Guglielmi A, Hugh T, Aldrighetti L, Endo I, Pawlik TM. Moazzam Z, et al. Among authors: endo y, endo i. Surgery. 2022 Nov;172(5):1448-1455. doi: 10.1016/j.surg.2022.07.019. Epub 2022 Aug 26. Surgery. 2022. PMID: 36031442
[No title available]
[No authors listed] [No authors listed] PMID: 36097298
A comprehensive preoperative predictive score for post-hepatectomy liver failure after hepatocellular carcinoma resection based on patient comorbidities, tumor burden, and liver function: the CTF score.
Alaimo L, Endo Y, Lima HA, Moazzam Z, Shaikh CF, Ruzzenente A, Guglielmi A, Ratti F, Aldrighetti L, Marques HP, Cauchy F, Lam V, Poultsides GA, Popescu I, Alexandrescu S, Martel G, Hugh T, Endo I, Pawlik TM. Alaimo L, et al. Among authors: endo y, endo i. J Gastrointest Surg. 2022 Dec;26(12):2486-2495. doi: 10.1007/s11605-022-05451-5. Epub 2022 Sep 13. J Gastrointest Surg. 2022. PMID: 36100827
3,395 results